DEC 11, 2017 7:46 AM PST

First-Ever Gene Therapy for Babies with "Bubble Boy" Disease

WRITTEN BY: Kara Marker

There is a genetic disorder affecting the immune system so severely that its patients often require protective isolation, hence the disease’s nickname: “Bubble Boy Disease.” Scientists know this disease as X-linked severe combined immunodeficiency disorder (XSCID). From the St. Jude Children’s Research Hospital, scientists conduct the first-ever clinical trial in infants with XSCID to test the effectiveness of the newest gene therapy approach to treating the disease.

XSCID gene therapy has been well tolerated and effective for infants as young as 2 months old. Credit: St. Jude Children's Research Hospital

Babies born with XSCID have a mutation in the IL2RG gene, which is normally responsible for making a protein called the “common gamma chain.” Without this protein, the immune system’s function is critically impaired, as immune cells like T cells, B cells, and natural killer cells fail to effectively grow and mature. XCID affects a disproportionate amount of boys, and untreated individuals die of infections without an immune system for protection.

Current treatment for XSCID relies on something that more than 80 percent of XSCID patients don’t even have: a tissue-matched sibling donor for transplantation. Incomplete genetic matches such as parents can act as donors, but the transplantation is fraught with complications and the procedure is much less likely to effectively rejuvenate the immune system.

The new gene therapy from St. Jude provides an alternative to a tissue-matched sibling donor. Researchers instead developed a lentiviral vector, which carries a normal copy of the IL2RG gene and delivers it into the hematopoietic stem cells of patients with XSCID. This treatment also contains certain features to promote safety and effectiveness.

The treatment process involves remove bone marrow so the hematopoietic stem cells can incubate with the lentiviral vector carrying normal IL2RG. Afterward, the stem cells are returned via transfusion.

The clinical trial at St. Jude enrolled seven patients between the ages of 2 and 13 months old. Four months after treatment, five patients had developed immune systems strong enough where they no longer needed protected isolation, containing near normal levels of T, B, and natural killer cells of the immune system, and nearly all were carrying the normal version of the IL2RG gene.

"These results are an exciting early indication that this gene therapy is well tolerated and effective in infants as young as 2 months old with this devastating inherited immune disorder," explained St. Jude’s Ewelina Mamcarz, MD.

Mamcarz’s co-study leader, Brian Sorrentino, MD, agrees, saying that the findings “reinforce hope that gene therapy will prove to be safe and effective at restoring immune function early in life.”

Sources: Genetics Home Reference, St. Jude Children’s Research Hospital

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JAN 08, 2020
Microbiology
JAN 08, 2020
Researchers Discover Many New Viruses That are Carried by Insects
Zoonotic diseases are caused by infectious microorganisms like bacteria or viruses, and are passed between animals, including humans....
JAN 10, 2020
Genetics & Genomics
JAN 10, 2020
Making Bad Fat Turn Good
Researchers want to turn unhealthy white fat, which stores calories, to healthier brown or beige fat that burns calories....
FEB 09, 2020
Genetics & Genomics
FEB 09, 2020
Mosquitoes are Driven to Search for Heat in the Hunt for Meals
Mosquitoes can be dangerous disease vectors, and they infect and kill hundreds of thousands of people with illnesses like dengue, malaria, and West Nile Virus....
FEB 03, 2020
Neuroscience
FEB 03, 2020
Genetic Characterization of Bipolar Disorders, Major Depressive Disorder
Mood disorders, like Bipolar, Major Depressive Disorder, and Schizophrenia, among others, are difficult to define clinically.  Unlike disorders that a...
MAR 03, 2020
Cell & Molecular Biology
MAR 03, 2020
New CRISPR-HOT Technique Can Color Cells and Genes
Since the CRISPR/Cas9 editing tool was developed several years ago, many scientists have modified and improved it for different applications....
MAR 16, 2020
Genetics & Genomics
MAR 16, 2020
How To: Recombinant Protein Construct Design
Creating recombinant proteins has become much easier over the past few decades. However, those with the skills to do design such constructs are usually lim...
Loading Comments...